Key facts
- This page summarizes Gregory A. Ahlberg's Form 4 filing for ABBOTT LABORATORIES (ABT).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2023, 18:13.
Gregory A. Ahlberg - 28 Feb 2023 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)
- Reporting relationship
- SENIOR VICE PRESIDENT
- Issuer ticker
- ABT
- Reported as of
- 28 Feb 2023
- Net transaction value
- -$413,973
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2023, 18:13:43 UTC
- Prior SEC filing
- 22 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gregory A. Ahlberg by Jessica H. Paik, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gregory A. Ahlberg filed Form 4 for ABBOTT LABORATORIES (ABT) on 02 Mar 2023.
Change
- Previous filing in this sequence was filed on 22 Feb 2023.
- Current net transaction value: -$413,973.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ABT
transaction
Common shares without par value
Tax liability
- Transaction value
- $281,351
- Shares
- -2,820
- Change %
- -6.6%
- Price
- $99.77
- Shares after
- 39,737
- Date
- 28 Feb 2023
- Ownership
- Direct
ABT
transaction
Common shares without par value
Sale
- Transaction value
- $132,622
- Shares
- -1,317
- Change %
- -3.3%
- Price
- $100.70
- Shares after
- 38,420
- Date
- 01 Mar 2023
- Ownership
- Direct
ABT
holding
Common shares without par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 11,017
- Date
- 28 Feb 2023
- Ownership
- Profit Sharing Trust
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2023.
SEC remarks
The sale transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1(c).